Drug Discovery SaaS
AD3
Drug discovery at your fingertips
AI-driven drug discovery without the code — the partner built for experimentalists.
Why AD3
Our AI, ready to use — right in your browser
Nothing to set up. Open a browser and start — every job runs in the cloud.
Inspect binding poses and structures directly in an interactive Mol* 3D viewer.
Register a target by symbol, UniProt or PDB ID and run jobs — all saved in your workspace.
Launch complex discovery pipelines with a few clicks — no scripting required.
Small Molecule Discovery
Two flagship services you can run in the browser today.
Docking of Millions
Our core small-molecule engine — now a click away in your browser
Screen ~95.6M purchasable compounds against your target, inspect binding poses in the 3D viewer, then check prices and request a quote — all in the browser.
Deep MolScan
Find what your compound binds — across 18,000 proteins
Scan a compound against all 18,000 human proteins to map where it binds, then read an all-in-one report — off-target, safety, hepatotoxicity, hERG, and disease association.
Biologics Discovery
Design and characterization of peptide / protein drug candidates.
Generates target-binding peptide sequences and structures.
Designs compact mini-binder proteins against a target.
Antibody Discovery
Design and characterization of antibody candidates.
Designs de novo antibodies that specifically bind a target.
Predicts residue-level immunogenicity by identifying MHC class II binding epitopes.
Clusters antibodies by 3D paratope similarity for the same antigen.
Predicts cross-species epitope similarity from 3D antigen-surface features across human, mouse, rat, and rhesus monkey.
Your targets, your jobs — in one place
Register a target by symbol, UniProt or PDB ID — or upload your own compound library — then run any discovery or app job. Every result is saved, shareable, and revisitable in your workspace.
Apps
A toolbox of single-purpose apps across every phase.
Database
Internal data assets — including a structure-optimized Target DB.
Get Started
Explore AD3 today
A new drug-discovery paradigm — a few clicks, and let AI take it from there.